Javascript must be enabled to continue!
Current progress in strategies to profile transcriptomic m6A modifications
View through CrossRef
Various methods have been developed so far for detecting N6-methyladenosine (m6A). The total m6A level or the m6A status at individual positions on mRNA can be detected and quantified through some sequencing-independent biochemical methods, such as LC/MS, SCARLET, SELECT, and m6A-ELISA. However, the m6A-detection techniques relying on high-throughput sequencing have more effectively advanced the understanding about biological significance of m6A-containing mRNA and m6A pathway at a transcriptomic level over the past decade. Various SGS-based (Second Generation Sequencing-based) methods with different detection principles have been widely employed for this purpose. These principles include m6A-enrichment using antibodies, discrimination of m6A from unmodified A-base by nucleases, a fusion protein strategy relying on RNA-editing enzymes, and marking m6A with chemical/biochemical reactions. Recently, TGS-based (Third Generation Sequencing-based) methods have brought a new trend by direct m6A-detection. This review first gives a brief introduction of current knowledge about m6A biogenesis and function, and then comprehensively describes m6A-profiling strategies including their principles, procedures, and features. This will guide users to pick appropriate methods according to research goals, give insights for developing novel techniques in varying areas, and continue to expand our boundary of knowledge on m6A.
Title: Current progress in strategies to profile transcriptomic m6A modifications
Description:
Various methods have been developed so far for detecting N6-methyladenosine (m6A).
The total m6A level or the m6A status at individual positions on mRNA can be detected and quantified through some sequencing-independent biochemical methods, such as LC/MS, SCARLET, SELECT, and m6A-ELISA.
However, the m6A-detection techniques relying on high-throughput sequencing have more effectively advanced the understanding about biological significance of m6A-containing mRNA and m6A pathway at a transcriptomic level over the past decade.
Various SGS-based (Second Generation Sequencing-based) methods with different detection principles have been widely employed for this purpose.
These principles include m6A-enrichment using antibodies, discrimination of m6A from unmodified A-base by nucleases, a fusion protein strategy relying on RNA-editing enzymes, and marking m6A with chemical/biochemical reactions.
Recently, TGS-based (Third Generation Sequencing-based) methods have brought a new trend by direct m6A-detection.
This review first gives a brief introduction of current knowledge about m6A biogenesis and function, and then comprehensively describes m6A-profiling strategies including their principles, procedures, and features.
This will guide users to pick appropriate methods according to research goals, give insights for developing novel techniques in varying areas, and continue to expand our boundary of knowledge on m6A.
Related Results
N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
Background: N6-methyladenosine (m6A) modification is a part of epigenetic research that has gained increasing attention in recent years. m6A modification is widely involved in many...
Transcriptome-wide map of m6A circRNAs identified in a rat model of hypoxia mediated pulmonary hypertension
Transcriptome-wide map of m6A circRNAs identified in a rat model of hypoxia mediated pulmonary hypertension
Abstract
Background: Hypoxic pulmonary hypertension (HPH) is a lethal disease and lacks effective therapy. CircRNAs play significant roles in physiological process. Recentl...
N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS)
N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS)
Abstract
Background
Polycystic ovary syndrome (PCOS) is a multisystem-related disease whose pathophysiology is still unclear. Several regulators of ...
mRNAs encoding neurodevelopmental regulators have equal m6A stoichiometry in Drosophila neuroblasts and neurons
mRNAs encoding neurodevelopmental regulators have equal m6A stoichiometry in Drosophila neuroblasts and neurons
Abstract
N6-methyladenosine (m6A) is the most prevalent internal mRNA modification in metazoans and is particularly abundant in the central nervous system. The extent to wh...
Prognostic value of comprehensive typing based on m6A and gene cluster
Prognostic value of comprehensive typing based on m6A and gene cluster
Abstract
Background
Triple-negative breast cancer (TNBC) is resistant to targeted therapy with HER2 monoclonal antibodies and endocrine therapy because it lacks the estrog...
P1621m6A RNA-methylation in the progression of heart failure
P1621m6A RNA-methylation in the progression of heart failure
Abstract
Introduction
N6-Methyladenosine (m6A) is the most abundant modification of RNA and was found to be a dynamic and revers...
Epigenetic modification of m6A regulator proteins in cancer
Epigenetic modification of m6A regulator proteins in cancer
AbstractDivergent N6-methyladenosine (m6A) modifications are dynamic and reversible posttranscriptional RNA modifications that are mediated by m6A regulators or m6A RNA methylation...
Abstract 5961: The roles of METTL3 in colorectal cancer
Abstract 5961: The roles of METTL3 in colorectal cancer
Abstract
Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide, accounting for 10% of all cancer deaths. Metastatic disease occurs in h...

